Avaforce 100 Mg belongs to a class of medications called phosphodiesterase type 5 (PDE5) inhibitors, primarily used to treat erectile dysfunction by enhancing blood flow. Its mechanism of action involves inhibiting the enzyme PDE5, leading to relaxation of smooth muscle cells and vasodilation. While initially developed for erectile dysfunction, researchers have begun to investigate its potential applications beyond health. Emerging research suggests that Avaforce's mechanism of action may extend beyond its primary indication. By modulating nitric oxide pathways and influencing immune responses, Avaforce could potentially mitigate inflammation and tissue damage associated with autoimmune diseases. Preliminary studies and case reports have shown promising results, indicating improvements in disease activity and symptoms among patients with conditions such as rheumatoid arthritis and systemic sclerosis.